Subjects: Antibodies, Monoclonal - Digital Collections - National Library of Medicine Search Results

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

NLM Digital Collections

Start Over Subjects Antibodies, Monoclonal

1. COVID-19: potency assay considerations for monoclonal antibodies and other therapeutic proteins targeting SARS-CoV-2 infectivity

Publication:: [Silver Spring, MD] : Center for Drug Evaluation and Research, January 2021
Subject(s):: Antibodies, Monoclonal
COVID-19 Drug Treatment
Enzyme-Linked Immunosorbent Assay
SARS-CoV-2
Viral Plaque Assay
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

2. JAK inhibitors and monoclonal antibodies for the treatment of atopic dermatitis: final policy recommendations

Publication:: [Boston, Massachusetts] : Institute for Clinical and Economic Review, August 17, 2021
Subject(s):: Antibodies, Monoclonal
Dermatitis, Atopic
Janus Kinase Inhibitors
United States

3. Valoctocogene roxaparvovec and emicizumab for hemophilia A without inhibitors: effectiveness and value : final report

Author(s):: Rind, David M., author
Walton, Surrey M., author
Agboola, Foluso, author
Herron-Smith, Serina, author
Quach, Danny, author
Chapman, Rick M., author
Pearson, Steven D., author
Bradt, Pamela, author
Publication:: [Boston, Massachusetts] : Institute for Clinical and Economic Review, November 20, 2020
Subject(s):: Antibodies, Monoclonal
Genetic Therapy
Hemophilia A -- drug therapy
United States

4. Aducanumab for Alzheimer’s disease: effectiveness and value : final evidence report and meeting summary

Author(s):: Lin, Grace A., author
Whittington, Melanie D., author
Synnott, Patricia G., author
McKenna, Avery, author
Campbell, Jon, author
Pearson, Steven D., author
Rind, David M., author
Publication:: [Boston, Massachusetts] : Institute for Clinical and Economic Review, August 5, 2021
Subject(s):: Alzheimer Disease -- drug therapy
Antibodies, Monoclonal
United States

5. Development of monoclonal antibody products targeting SARS-CoV-2 for emergency use authorization: guidance for industry

Publication:: Silver Spring, MD : Center for Drug Evaluation and Research, December 2023
Subject(s):: Antibodies, Monoclonal
COVID-19 Drug Treatment
Drug Approval
Drug Industry
Government Regulation
Legislation, Drug
SARS-CoV-2
United States

6. Monoclonal antibodies in renal research

Publication:: [Bethesda, Md. : Medical Arts and Photography Branch, National Institutes of Health, 1984]
Subject(s):: Kidney
Antibodies, Monoclonal